AUPH
Aurinia Pharmaceuticals
PE ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: AUPH
- PE Ratio
The current price-to-earnings ratio for Aurinia Pharmaceuticals stock as of Jun 30, 2026 is 7.61. This is calculated based on the current EPS of $2.23 and the stock price of $16.97 per share. The PE ratio has decreased by 42% from the past four quarters average of 13.1.
AUPH PE ratio history
The average historical PE ratio of Aurinia Pharmaceuticals for the last two years is 50.77. The current price-to-earnings ratio of 7.61 is 85% less than the historical average. In the past two years, AUPH's PE ratio reached its highest point in the Dec 2024 quarter at 224.5, when the stock price was $8.98 and the EPS was $0.04. The lowest point was recorded in the Mar 2026 quarter, when it reached 6.65 with a price of $14.82 and an EPS of $2.23.
Aurinia Pharmaceuticals PE ratio by year
Maximum annual decrease: -96.68% in 2025
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 7.45 | -96.68% | $15.95 | $2.14 |
| 2024 | 224.5 | N/A | $8.98 | $0.04 |
| 2023 | N/A | N/A | $8.99 | -$0.54 |
| 2022 | N/A | N/A | $4.32 | -$0.76 |
| 2021 | N/A | N/A | $22.87 | -$1.4 |
| 2020 | N/A | N/A | $13.83 | -$0.87 |
| 2019 | N/A | N/A | $20.26 | -$0.95 |
| 2018 | N/A | N/A | $6.82 | -$0.63 |
| 2017 | N/A | N/A | $4.53 | -$0.92 |
| 2016 | N/A | N/A | $2.1 | -$0.66 |
| 2015 | N/A | N/A | $2.47 | -$0.58 |
| 2014 | N/A | N/A | $3.64 | -$0.67 |
| 2013 | N/A | N/A | N/A | -$0.42 |
| 2012 | N/A | N/A | N/A | -$2.73 |
Aurinia Pharmaceuticals PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2026 | 6.65 | -10.74% | $14.82 | $2.23 |
| Dec 2025 | 7.45 | -60.89% | $15.95 | $2.14 |
| Sep 2025 | 19.05 | -1.04% | $11.05 | $0.58 |
| Jun 2025 | 19.25 | -30.56% | $8.47 | $0.44 |
| Mar 2025 | 27.72 | -87.65% | $8.04 | $0.29 |
| Dec 2024 | 224.5 | N/A | $8.98 | $0.04 |
| Sep 2024 | N/A | N/A | $7.33 | -$0.14 |
| Jun 2024 | N/A | N/A | $5.71 | -$0.33 |
| Mar 2024 | N/A | N/A | $5.01 | -$0.42 |
| Dec 2023 | N/A | N/A | $8.99 | -$0.54 |
| Sep 2023 | N/A | N/A | $7.77 | -$0.53 |
| Jun 2023 | N/A | N/A | $9.68 | -$0.5 |
| Mar 2023 | N/A | N/A | $10.96 | -$0.67 |
| Dec 2022 | N/A | N/A | $4.32 | -$0.76 |
| Sep 2022 | N/A | N/A | $7.52 | -$0.83 |
AUPH Price vs fair value
AUPH average PE ratio chart
What this chart measures
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
Percentile logic
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
Regime map
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
How to read each part
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Important metric definitions
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
How to use it well
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
The current PE ratio of AUPH is lower than the 3, 5 and 10-year averages.
PE comparison
Aurinia Pharmaceuticals's P/E of 7.61 is below the Healthcare sector and the industry average. Looking at its Healthcare sector average of 25.16, Aurinia Pharmaceuticals's P/E is 70% lower.
AUPH PE vs peers
| Stock name | PE ratio | Market cap |
|---|---|---|
| AUPH Aurinia Pharmaceuticals Inc | 7.61 | $2.18B |
| QURE uniQure NV | N/A | $2.9B |
| LXRX Lexicon Pharmaceuticals Inc | N/A | $1.07B |
Frequently asked questions
What is Aurinia Pharmaceuticals's PE ratio?
The price to earnings ratio for AUPH stock as of Jun 30, 2026, stands at 7.61.
What is the 3-year average PE ratio for Aurinia Pharmaceuticals (AUPH)?
The 3-year average PE ratio for AUPH stock is 50.77.
What is the 5-year average PE ratio for Aurinia Pharmaceuticals (AUPH)?
The 5-year average PE ratio for AUPH stock is 50.77.
What is the highest PE ratio for AUPH?
The highest quarterly PE ratio in the last two years has been 224.5 and it was in the Dec 2024 quarter.
How does the current PE ratio for AUPH compare to its historical average?
The current price to earnings ratio of AUPH is 85% lower than the 2-year historical average.
Why is Aurinia Pharmaceuticals's PE ratio so low?
AUPH's stock price is trading at a lower multiple of earnings, which is why its PE ratio of 7.61 is considered low.
How is AUPH's PE ratio calculated (Aurinia Pharmaceuticals PE ratio formula)?
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months earnings per share(EPS). As of today (Jun 30, 2026), Aurinia Pharmaceuticals's stock price is $16.97. The earnings per share for the trailing twelve months (TTM) ending Mar 2026 is $2.23. Therefore, Aurinia Pharmaceuticals's price to earnings ratio for today is 7.61. PE RATIO(7.61) = STOCK PRICE($16.97) / TTM EPS($2.23)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.